ProFunds Biotechnology UltraSector Svc (BIPSX)

Fund Assets	132.73M
Expense Ratio	2.52%
Min. Investment	$5,000
Turnover	52.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 19, 2025

Previous Close	47.01
YTD Return	34.78%
1-Year Return	98.55%
5-Year Return	-16.21%
52-Week Low	23.83
52-Week High	54.53
Beta (5Y)	1.26
Holdings	157
Inception Date	Jun 19, 2000

About BIPSX

ProFunds Biotechnology UltraSector Fund Service Class is a leveraged mutual fund designed to deliver daily investment results that correspond to one and one-half times (1.5x) the daily performance of the S&P Biotechnology Select Industry Index. This fund employs derivatives and other financial instruments to amplify exposure to the U.S. biotechnology sector, making it suitable for investors seeking focused, short-term trades on biotech market movements. The fund is non-diversified and includes holdings from companies engaged primarily in biotechnology, with significant positions in both leading biotech firms and major financial counterparties to support its leveraged strategy. As a passively managed fund, it tracks its target index closely but with increased volatility and risk due to its leverage. The ProFunds Biotechnology UltraSector Fund Service Class plays a specialized role in the market by providing tactical access to the biotechnology industry, allowing investors to express strong convictions about short-term sector performance or to hedge broader portfolios with a targeted, amplified biotech allocation.

• Fund Family: ProFunds
• Category: Trading--Leveraged Equity
• Performance Rating: Average
• Risk Rating: High
• Stock Exchange: NASDAQ
• Ticker Symbol: BIPSX
• Share Class: Service Class
• Index: Dow Jones US Biotechnology TR

Performance

BIPSX had a total return of 98.55% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.86%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
BIPIX	Investor Class	1.52%

Top 10 Holdings

35.62% of assets

Name	Symbol	Weight
HSBC SECURITIES (USA), INC. B 3.5 , 5/01/2026	n/a	8.47%
SOCIETE' GENERALE 3.52 , 5/01/2026	n/a	7.20%
CF Secured 3.52 , 5/01/2026	n/a	6.36%
NATWEST MARKETS PLC 3.51 , 5/01/2026	n/a	4.24%
UMB FINANCIAL CORP. 3.37 , 5/01/2026	n/a	2.11%
Invesco Shrt-Trm Inv Gov&Agcy Instl	AGPXX	2.05%
ROYAL BANK OF CANADA 3.42 , 5/01/2026	n/a	1.48%
Apellis Pharmaceuticals, Inc.	APLS	1.35%
Revolution Medicines, Inc.	RVMD	1.19%
Travere Therapeutics, Inc.	TVTX	1.17%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 19, 2025	$0.01967	Dec 22, 2025
Dec 27, 2024	$13.04498	Dec 30, 2024
Dec 20, 2023	$4.12801	Dec 21, 2023
Dec 21, 2020	$8.0736	Dec 21, 2020
Dec 23, 2019	$2.02988	Dec 23, 2019
Dec 27, 2018	$2.86745	Dec 27, 2018

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 18, 2026

Data Sources Report a data error